ReviR Therapeutics Raises $30M Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders July 30, 2024
Unnatural Products, Inc. Announces $32 Million in Series A Funding to Pair AI And Chemistry to Target Therapeutics December 29, 2023
ReviR Therapeutics Raises $30M Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders July 30, 2024
Unnatural Products, Inc. Announces $32 Million in Series A Funding to Pair AI And Chemistry to Target Therapeutics December 29, 2023